HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Allogeneic transplantation, Fas signaling, and dysregulation of hepcidin.

Abstract
Hepatic iron overload is common in patients undergoing hematopoietic cell transplantation. We showed previously in a murine model that transplantation of allogeneic T cells induced iron deposition and down-regulation of hepcidin (Hamp) in hepatocytes. We hypothesized that hepatic injury was related to disrupted iron homeostasis triggered by the interaction of Fas-ligand, expressed on activated T cells, with Fas on hepatocytes. In the current study, we determined the effects of modified expression of the Flice inhibitory protein (FLIP long [FLIPL]), which interferes with Fas signaling, on the impact of Fas-initiated signals on the expression of IL-6 and Stat3 and their downstream target, Hamp. To exclude a possible contribution by other pathways, we used agonistic anti-Fas antibodies (rather than allogeneic T cells) to trigger Fas signaling. Inhibition of FLIPL by RNA interference resulted, as expected, not only in enhanced hepatocyte apoptosis in response to Fas signals, but also in decreased levels of IL-6, Stat3, and Hamp. In contrast, overexpression of FLIPL protected hepatocytes against agonistic anti-Fas antibody-mediated apoptosis and increased the levels of IL-6 and Stat3, thereby maintaining the expression of Hamp in an NF-κB-dependent fashion. In vivo overexpression of FLIPL in the liver via hydrodynamic transfection, similarly, interfered with Fas-initiated apoptosis and prevented down-regulation of IL-6, Stat3, and Hamp. These data indicate that Fas-dependent signals alter the regulation of iron homeostasis and suggest that signals initiated by Fas may contribute to peritransplantation iron accumulation.
AuthorsXiang Li, Feng Xu, Ekapun Karoopongse, A Mario Marcondes, Kayoung Lee, Kris V Kowdley, Carol H Miao, Grant D Trobridge, Jean S Campbell, H Joachim Deeg
JournalBiology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation (Biol Blood Marrow Transplant) Vol. 19 Issue 8 Pg. 1210-9 (Aug 2013) ISSN: 1523-6536 [Electronic] United States
PMID23707854 (Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't)
CopyrightCopyright © 2013 American Society for Blood and Marrow Transplantation. Published by Elsevier Inc. All rights reserved.
Chemical References
  • Antibodies, Monoclonal
  • CASP8 and FADD-Like Apoptosis Regulating Protein
  • Fas Ligand Protein
  • Hepcidins
  • Interleukin-6
  • STAT3 Transcription Factor
  • fas Receptor
Topics
  • Animals
  • Antibodies, Monoclonal (immunology, pharmacology)
  • Apoptosis (physiology)
  • CASP8 and FADD-Like Apoptosis Regulating Protein (antagonists & inhibitors, biosynthesis, metabolism)
  • Cell Line, Tumor
  • Fas Ligand Protein (metabolism)
  • Female
  • Hepatocytes (immunology, metabolism)
  • Hepcidins (biosynthesis, genetics, metabolism)
  • Humans
  • Interleukin-6 (biosynthesis, genetics)
  • Iron Overload (etiology, genetics, metabolism)
  • Mice
  • Mice, Inbred C57BL
  • STAT3 Transcription Factor (biosynthesis, genetics)
  • Signal Transduction
  • T-Lymphocytes (immunology, metabolism, transplantation)
  • Transfection
  • Transplantation, Homologous
  • Treatment Outcome
  • fas Receptor (immunology, metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: